Compare BDL & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDL | BTMD |
|---|---|---|
| Founded | 1959 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.6M | 72.7M |
| IPO Year | 1995 | 2021 |
| Metric | BDL | BTMD |
|---|---|---|
| Price | $30.50 | $1.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 1.2K | ★ 177.1K |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | 49.72 | ★ 722.22 |
| EPS | ★ 1.98 | 0.06 |
| Revenue | ★ $205,248,000.00 | $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ $15.40 | $33.67 |
| Revenue Growth | ★ 8.99 | N/A |
| 52 Week Low | $22.61 | $1.27 |
| 52 Week High | $35.98 | $4.75 |
| Indicator | BDL | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 43.79 |
| Support Level | $28.82 | $1.35 |
| Resistance Level | $33.69 | $2.20 |
| Average True Range (ATR) | 1.46 | 0.13 |
| MACD | 0.07 | -0.04 |
| Stochastic Oscillator | 29.29 | 3.80 |
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.